JFBRW Jeffs Brands Ltd

Exhibit 99.2

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

For the Six Months Ended June 30, 2024.

 

Cautionary Note Regarding Forward-Looking Statements

 

Certain information included herein may be deemed to be “forward-looking statements”. Forward-looking statements are often characterized by the use of forward-looking terminology such as “may,” “will,” “expect,” “anticipate,” “estimate,” “continue,” “believe,” “should,” “intend,” “project” or other similar words, but are not the only way these statements are identified.

 

These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition, expected capital needs and expenses, statements relating to the research, development, completion and use of our products, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.

 

Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate.

 

Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements include, among other things:

 

	●	our ability to raise capital through the issuance of additional securities;
	●	our belief that our existing cash and cash equivalents as of June 30, 2024, will be sufficient to fund our operations through the next twelve months;
	●	our ability to adapt to significant future alterations in Amazon’s policies;
	●	our ability to sell our existing products and grow our brands and product offerings, including by acquiring new brands and expanding into new territories;
	●	our ability to meet our expectations regarding the revenue growth and the demand for e-commerce;
	●	our ability to enter into definitive agreements for our current letters of intent and term sheet;
	●	the overall global economic environment;
	●	the impact of competition and new e-commerce technologies;
	●	general market, political and economic conditions in the countries in which we operate;
	●	projected capital expenditures and liquidity;
	●	the impact of competition and new e-commerce technologies;
	●	our ability to retain key executive members;
	●	the impact of possible changes in Amazon’s policies and terms of use;

 

 

●

projected capital expenditures and liquidity;

 

	●	our expectations regarding our tax classifications;
	●	how long we will qualify as an emerging growth company or a foreign private issuer;
	●	interpretations of current laws and the passages of future laws;
	●	changes in our strategy;
	●	general market, political and economic conditions in the countries in which we operate including those related to recent unrest and actual or potential armed conflict in Israel and other parts of the Middle East, such as the Israel-Hamas war; and
	●	litigation.

 

The foregoing list is intended to identify only certain of the principal factors that could cause actual results to differ. For a more detailed description of the risks and uncertainties affecting our company, reference is made to our Annual Report on Form 20-F for the year ended December 31, 2023, or our Annual Report, filed with the Securities and Exchange Commission, or the SEC, on April 1, 2024, and the other risk factors discussed from time to time by our company in reports filed or furnished to the SEC.

 

Except as otherwise required by law, we undertake no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

General

 

Introduction

 

Unless indicated otherwise by the context, all references in this report to “Jeffs’ Brands”, the “Company”, “we”, “us” or “our” are to Jeffs’ Brands Ltd. When the following terms and abbreviations appear in the text of this report, they have the meanings indicated below:

 

	●	“dollars” or “$” means United States dollars; and
	●	“NIS” means New Israeli Shekels.

 

You should read the following discussion and analysis in conjunction with our unaudited consolidated financial statements for the six months ended June 30, 2024, and notes thereto, and together with our audited consolidated financial statements for the year ended December 31, 2023 and notes thereto included in our Annual Report filed with the SEC.

 

Unless otherwise indicated, dollars are in thousands.

 

Overview

 

We are an e-commerce consumer products goods, or CPG, company, operating primarily on Amazon. We were incorporated in Israel in March 2021, under the name Jeffs’ Brands Ltd. Together with five of our wholly-owned subsidiaries – Smart Repair Pro, Top Rank Ltd, or Top Rank, Fort Products LLC, or Fort, and Jeffs’ Brands Holdings Inc., or Jeffs’ Brands Holdings, we operate online stores for the sale of various consumer products on the Amazon marketplace online marketplace, or Amazon, utilizing the fulfillment by Amazon, or the FBA model.

 

In addition to executing the FBA business model, we utilize internal methodologies to analyze sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and growth, and for maximizing sales of existing proprietary products. We also use our own skills, know-how and profound familiarity with the Amazon algorithm and all the tools that the FBA platform FBA has to offer. In some circumstances we scale the products and improve them. 

 

 

Comparison of the Six Months Ended June 30, 2024, and 2023

 

Results of Operations

 

The following table summarizes our results of operations for the periods presented:

 

		Six Months Ended June 30,
U.S. dollars in thousands		2024				2023
Revenues			6,198				3,871
Cost of sales			5,441				3,498
Gross profit			757				373
Sales and marketing			603				342
General and administrative			2,413				2,067
Equity losses			245				89
Other income, net			(60	)			(158	)
Operating loss			(2,444	)			(1,967	)
Financial expenses (income), net			1,367				(148	)
Tax expenses			64				9
Net loss for the period			(3,875	)			(1,828	)

 

Revenues

 

Our revenues consist of revenue which mainly derived from sales on Amazon marketplace.

 

Our revenues for the six months ended June 30, 2024, were $6,198 compared to $3,871 for the six months ended June 30, 2023. This represents an increase of $2,327 or 60%. The increase was primarily attributable to the increase in revenues generated by Fort of approximately $2,410, during the six months ended June 30, 2024, compared to the period beginning on March 9, 2023 (the date on which we acquired Fort) until June 30, 2023, partially offset by a decrease in revenues of $85 for our remaining brands.

 

Cost of goods sold

 

Our cost of goods sold consist of the purchase of finished goods, freight, cost of commissions to Amazon and other e-commerce platforms, salary and change in inventory.

 

The following table sets forth the breakdown of cost of goods sold for the periods set forth below:

 

		Six Months Ended June 30,
U.S. dollars in thousands		2024				2023
Purchases of finished goods and changes in inventory		$	1,971			$	1,270
Freight			310				158
Storage			264				363
Salaries			71				48
Cost of commissions			2,825				1,659
Total			5,441				3,498

  

 

Our cost of goods sold for the six months ended June 30, 2024, was $5,441 compared to $3,498 for the six months ended June 30, 2023. This represents an increase of $1,943 or 58%. The increase was primarily attributable to: (i) an increase in purchases of finished goods and changes in inventory of $701, associated with the increase in revenues generated by Fort during the six months ended June 30, 2024, compared to the period beginning on March 9, 2023 (the date on which we acquired Fort) until June 30, 2023; (ii) a decrease in storage expenses of $99 due to a decrease in inventory kept in warehouses; (iii) an increase in cost of commissions, mainly paid to Amazon, of $1,166 due to an increase in sales; (iv) an increase in freight charges of $152 attributable to purchases of inventory from suppliers abroad by Fort; and (v) an increase in shipment costs as a result of the attacks conducted by the Houthi movement in Yemen against marine vessels traversing the Red Sea and thought to either be in route towards Israel or to be partly owned by Israeli businessmen.

 

Gross Profit

 

Our gross profit for the six months ended June 30, 2024 was $757 compared to gross profit of $373 for the six months ended June 30, 2023. This represents an increase of $384, or 102.9%. The increase was primarily due to an increase in revenues offset by increase in cost of sales, as described above.

 

Operating Expenses, net

 

Our current operating expenses consist of four components: marketing and sales expenses: general and administrative expenses; equity losses; and other income.

 

Marketing and Sales Expenses

 

Our marketing and sales expenses consist primarily of Amazon marketing fees, consultant fees and other marketing and sales expenses.

 

The following table sets forth the breakdown of marketing and sales expenses for the periods set forth below:

 

		Six Months Ended June 30,
U.S. dollars in thousands		2024				2023
Advertising		$	567			$	330
Other			36				12
Total			603				342

 

Our marketing and sales expenses for the six months ended June 30, 2024 were $603 compared to expenses of $342 for the six months ended June 30, 2023, representing an increase of $261, or 76%. The increase was primarily attributable to the increase in our advertising costs on Amazon.

 

General and Administrative Expenses

 

Our general and administrative expenses consist primarily of salaries and related expenses, professional service fees, legal, amortization of intellectual property assets and other general and administrative expenses.

 

 

The following table sets forth the breakdown of our general and administrative expenses for the periods set forth below:

 

		Six Months Ended June 30,
U.S. dollars in thousands		2024				2023
Payroll and related expenses		$	641			$	500
Subcontractors			7				46
Professional services and consulting fees			731				547
Director fees			143				158
Rent and office maintenance			99				71
Amortization of intangible assets			390				350
Insurance			136				196
Other expenses			266				199
Total			2,413				2,067

  

Our general and administrative expenses for the six months ended June 30, 2024 were $2,413 compared to $2,067 for the six months ended June 30, 2023, representing an increase of $346, or 16.7%. The increase was primarily attributable to an increase in the number of employees of the Company, payments to consultants and increase in revenue sharing costs due to an increase in the Company’s revenue.

 

Other Income

 

Our other income for the six months ended June 30, 2024 was $60 compared to $158 for the six months ended June 30, 2023. The decrease is primarily attributable to a decrease in management fees paid to SciSparc Nutraceuticals Inc. from $20 to $10, effective as of November 2023, pursuant to the amendment, dated as of September 4, 2024 to our existing agreement with SciSparc Nutraceuticals Inc.

 

Share of Losses Accounted for at Equity

 

Our share of losses accounted for as equity for the six months ended June 30, 2024 was $245 compared to $89 for the six months ended June 30, 2023. The increase was attributable to losses derived from our investment in SciSparc Nutraceuticals Inc.

 

Operating Loss

 

Our operating loss for the six months ended June 30, 2024 was $2,444, compared to operating loss of $1,967 for the six months ended June 30, 2023, an increase of $477, or 24%. The increase was attributable to the changes in revenues, cost of sales and operating expenses, as described above.

 

Financial expenses (income), net

 

Our financial expenses, net was $1,367 for the six months ended June 30, 2024, compared to financial income, net of $148 for the six months ended June 30, 2023, an increase of $1,515. The increase in financial expenses, net was primarily attributable to an increase in losses mainly in connection with the January 2024 PIPE (as defined below), Series A Warrants revaluation losses of approximately $1,071, issuance cost on derivative liabilities of $603 offset by an increase of $56 in interest from short term deposit, and a decrease in exchange rate fluctuations of $82, mainly attributed to lower amounts of NIS held in bank accounts.

 

Net loss for the period

 

Our net loss for the six months ended June 30, 2024 was $3,875, compared to net loss of $1,828 for the six months ended June 30, 2023, an increase of $2,047, or 112%. The increase was primarily attributable to an increase in operating expenses and a decrease in gross profit, as described above.

 

 

Critical Accounting Estimates

 

We describe our significant accounting policies more fully in Note 2 to our unaudited financial statements for the six months ended June 30, 2024. There have been no material changes to our critical accounting policies as described in our Annual Report other than as described in Note 2 to our unaudited consolidated financial statements for the six months ended June 30, 2024. We believe that the accounting policies described below and in Note 2 to unaudited financial statements for the six months ended June 30, 2024, are critical in order to fully understand and evaluate our financial condition and results of operations.

 

The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates.

 

Liquidity and Capital Resources

 

Overview

 

Since Jeffs’ Brands’ inception in March 2021 to date, we have financed our operations primarily through funds we received from loans and proceeds from sales on Amazon (after deducting FBA fees and advertising fees) and the issuance of ordinary shares, no par value per share, or Ordinary Shares, and warrants. As of June 30, 2024 and 2023, we had approximately $2,815 and $2,153, respectively, in cash and cash equivalents.

 

The table below presents our cash flow for the periods indicated:

 

		Six Months Ended June 30,
U.S. dollars in thousands		2024				2023
Net cash used in operating activities		$	(3,534	)		$	(1,169	)
Net cash used in investing activities			(436	)			(4,683	)
Net cash from (used in) financing activities			6,255				(86	)
Net increase (decrease) in cash and cash equivalents			2,285				(5,938	)

 

We expect that for the foreseeable future we will finance our activities using the proceeds from sales of our existing and future brands.

 

Operating Activities

 

Our net cash used in operating activities was $3,534 for the six months ended June 30, 2024, compared to net cash from operating activities of $1,169 for the six months ended June 30, 2023, representing an increase of $2,365, or 239%. The increase was primarily attributable to an increase in net loss for the period of $2,047, an increase in inventory of $1,216, a decrease in accounts payable and other payables in the amount of $777, partially offset by an increase in change in fair value of derivative liabilities of $1,071 and issuance cost on derivative liabilities of $603.

 

Investing Activities

 

Our net cash used in investing activities was $436 for the six months ended June 30, 2024, compared to net cash used in financing activities of $4,683 for the six months ended June 30, 2023, representing a decrease of $4,247. The decrease was primarily attributable to the acquisition of an interest in SciSparc Nutraceuticals Inc. for $2,993 and the acquisition of Fort for $1,682 during the six months ended June 30, 2023, compared to payments related to the acquisition of an interest in SciSparc Nutraceuticals Inc. for $98 and the acquisition of Fort for $330 during the six months ended June 30, 2024.

 

Financing Activities

 

Our net cash used in financing activities was $6,255 for the six months ended June 30, 2024, compared to net cash provided by investing activities of $86 for the six months ended June 30, 2023, representing an increase of $6,341. The change was attributable to the proceeds from the January 2024 PIPE, net of issuance costs, offset by the repayment of loan in the aggregate amount of $86 during the six months ended June 30, 2023.

 

Financial Arrangements 

 

  On January 29, 2024, we completed a private placement transaction, or the January 2024 PIPE, in which we issued Ordinary Shares; Pre-Funded Warrants to purchase Ordinary Shares; Series A Warrants to purchase Ordinary Shares and Series B Warrants to purchase Ordinary Shares, for aggregate gross proceeds of approximately $7.275 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the January 2024 PIPE.

 

 

The Pre-Funded Warrants were immediately exercisable at an exercise price of $0.00001 per Ordinary Share and do not expire until exercised in full. The Series A Warrants were immediately exercisable, have an exercise price of $2.69 per whole Ordinary Share (subject to certain anti-dilution and share combination event protections) and have a term of sixty-six (66) months from the date of issuance. The Series B Warrants will be exercisable following the Reset Date (as defined below), have an exercise price of $0.00001 per Ordinary Share and have a term of sixty-six (66) months from the date of issuance. The exercise price and number of Ordinary Shares issuable under the Series A Warrants are subject to adjustment and the number of Ordinary Shares issuable under the Series B Warrant will be determined following the reset date, or the Reset Date, which is the earliest to occur of: (i) the date on which a resale registration statement covering the resale of all registrable securities has been declared effective for 30 consecutive trading days, (ii) the date on which the selling shareholders may sell the registrable securities pursuant to Rule 144 under the Securities Act of 1933, as amended for a period of 30 consecutive trading days, and (iii) 12 months and 30 days following the issuance date of the Series B Warrant, to be determined pursuant to the lowest daily average trading price of the Ordinary Shares during a period of 20 trading days, subject to a pricing floor of $0.68, or Pricing Floor. As our Ordinary Shares are currently trading at a price per share lower than the Pricing Floor, on the Reset Date: (i) the Series A Warrants will be exercisable into a total number of 13,373,177 Ordinary Shares, subject to certain anti-dilution and share combination event mechanisms, at an exercise price of $0.68, and (ii) the Series B Warrants will be exercisable into a total number of 7,904,181 Ordinary Shares. As of September 30, 2024, the date our consolidated financial statements for the six months period ended June 30, 2024 were issued, Pre-Funded Warrants to purchase up to 820,000 Ordinary Shares and Series B Warrants to purchase up to 5,257,127 had been exercised for an aggregate issuance of 6,077,127 Ordinary Shares.

 

Current Outlook

 

We have financed our operations to date primarily through proceeds from our initial public offering, the January 2024 PIPE and proceeds from sales on the different Amazon platforms (after FBA fees and advertising fees).

 

As of June 30, 2024, our cash and cash equivalents were $2,815. We expect that our existing cash and cash equivalents as of June 30, 2024, will be sufficient to fund our current operations for the next twelve months. In addition, our operating plans may change as a result of many factors that may currently be unknown to us, and we may need to seek additional funds sooner than planned. Our future capital requirements will depend on many factors, including:

 

●

the progress and costs of purchasing new brands and their development plans;

 

●

the costs of manufacturing and shipment of our products;

 

●

the costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;

  

●

the potential costs of contracting with third parties to provide marketing and distribution services for us or for building such capacities internally; and

 

●

the magnitude of our general and administrative expenses.

 

Quantitative and Qualitative Disclosures about Market Risk

 

We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of U.S. dollar to NIS exchange rates and U.S. dollar to GBP, which is discussed in detail in the following paragraph.

 

Impact of Inflation and Currency Fluctuations

 

Our functional and reporting currency is U.S. dollar. We incur some of our income and expenses in other currencies. As a result, we are exposed to the risk that the rate of inflation in countries in which we are active other than the United States will exceed the rate of devaluation of such countries’ currencies in relation to the dollar or that the timing of any such devaluation will lag behind inflation in such countries.

 

Global inflation has risen in 2024. To date, we have not been subject to inflationary pressures. We cannot assure you that we will not be adversely affected in the future.

 

As of June 30, 2024, the annual rate of inflation in Israel was 2.90%. The NIS revaluated against the U.S. dollar by approximately 3.64% for the period ended June 30, 2024 and 5.14% for the period ended June 30, 2023.

 

 

7

 

v3.24.3

Document And Entity Information	6 Months Ended
	Jun. 30, 2024
Document Information Line Items
Entity Registrant Name	Jeffs’ Brands Ltd
Document Type	6-K
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001885408
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity File Number	001-41482

v3.24.3

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 2,815	$ 535
Restricted deposit	17	17
Trade receivables	396	629
Other receivables	445	597
Related party receivables	53
Inventory	4,354	2,386
Total current assets	8,080	4,164
NON-CURRENT ASSETS:
Property and equipment, net	61	59
Investment accounted for using the equity method	1,695	1,940
Investment at fair value	11	67
Intangible assets, net	5,330	5,714
Deferred taxes	195	168
Operating lease right-of-use assets	86	127
Total non-current assets	7,378	8,075
TOTAL ASSETS	15,458	12,239
CURRENT LIABILITIES:
Trade payables	521	709
Other payables	1,293	1,533
Related party payables	31	66
Total current liabilities	1,845	2,308
NON-CURRENT LIABILITIES:
Derivative liabilities	6,406	1,375
Operating lease liabilities	14	45
Total non-current liabilities	6,420	1,420
TOTAL LIABILITIES	8,265	3,728
SHAREHOLDERS’ EQUITY:
Ordinary shares, no par value per share - Authorized: 43,567,567 as of June 30, 2024 and December 31, 2023; Issued and outstanding: 9,177,100 shares as of June 30, 2024; and 1,215,512 shares as of December 31, 2023
Additional paid-in-capital	19,344	16,787
Accumulated deficit	(12,151)	(8,276)
TOTAL SHAREHOLDERS’ EQUITY	7,193	8,511
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 15,458	$ 12,239

v3.24.3

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Ordinary shares, par value (in Dollars per share)
Ordinary shares, Authorized	43,567,567	43,567,567
Ordinary shares, Issued	9,177,100	1,215,512
Ordinary shares, outstanding	9,177,100	1,215,512

v3.24.3

Condensed Consolidated Statements of Operations Unaudited - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenues	[1]	$ 6,198	$ 3,871
Cost of sales	[1]	5,441	3,498
Gross profit	[1]	757	373
Operating expenses:
Sales and marketing	[1]	603	342
General and administrative	[1]	2,413	2,067
Equity losses	[1]	245	89
Other income	[1]	(60)	(158)
Operating loss	[1]	(2,444)	(1,967)
Financial expenses (income), net	[1]	1,367	(148)
Loss before taxes	[1]	(3,811)	(1,819)
Tax expenses	[1]	64	9
Net loss for the period	[1]	$ (3,875)	$ (1,828)
Loss per ordinary share (basic and diluted) (in Dollars per share)	[1],[2]	$ (0.69)	$ (1.54)
Weighted-average ordinary shares used in computing net loss per share, basic and diluted (in Shares)	[1],[2]	5,586,274	1,173,097
[1] Except share and per share information [2] Share and per share data in these condensed consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023.

v3.24.3

Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($) $ in Thousands	Ordinary Shares	Additional paid-in- capital	Accumulated Deficit	Total
Balance at Dec. 31, 2022		$ 16,499	$ (3,678)	$ 12,821
Balance (in Shares) at Dec. 31, 2022	1,180,167
Net loss for the period			(1,828)	(1,828)	[1]
Issuance of ordinary shares to SciSparc Ltd. (see note 3b.)		288		288
Issuance of ordinary shares to SciSparc Ltd. (see note 3b.) (in Shares)	35,345
Balance at Jun. 30, 2023		16,787	(5,506)	11,281
Balance (in Shares) at Jun. 30, 2023	1,215,512
Balance at Dec. 31, 2023		16,787	(8,276)	$ 8,511
Balance (in Shares) at Dec. 31, 2023	1,215,512			1,215,512
Net loss for the period			(3,875)	$ (3,875)	[1]
Issuance of ordinary shares pre-funded warrants and warrants, net (note 4a.)		2,557		2,557
Issuance of ordinary shares pre-funded warrants and warrants, net (note 4a.) (in Shares)	1,884,461
Exercise of Series B Warrants (note 4a.)
Exercise of Series B Warrants (note 4a.) (in Shares)	5,257,127
Exercise of Pre-Funded Warrants (note 4a.)
Exercise of Pre-Funded Warrants (note 4a.) (in Shares)	820,000
Balance at Jun. 30, 2024		$ 19,344	$ (12,151)	$ 7,193
Balance (in Shares) at Jun. 30, 2024	9,177,100			9,177,100
[1] Except share and per share information

v3.24.3

Condensed Consolidated Statements of Cash Flows Unaudited - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
CASH FLOWS USED IN OPERATING ACTIVITIES:
Net loss for the period	[1]	$ (3,875)	$ (1,828)
Adjustments to reconcile net loss to net cash from (used in) operating activities:
Exchange differences on cash and cash equivalent		5	46
Finance expenses on lease liabilities		(3)
Amortization of intangible assets		384	347
Depreciation		6	3
Loss from change in the fair value of a financial asset at fair value		57	90
Equity losses	[1]	245	89
Change in fair value of derivative liabilities		730	(341)
Changes in deferred taxes, net		(27)	(27)
Issuance costs of financial instruments classified as derivative liabilities		603
Changes in operating assets and liabilities:
Decrease in trade receivables		233	196
Increase in related parties balance		(88)	(2)
Decrease (increase) in operating lease right-of-use assets		42	(30)
Increase (decrease) in operating lease liabilities		(42)	31
Decrease in other receivables		151	219
Increase in inventory		(1,968)	(752)
Increase (decrease) in accounts payable and other payables		13	790
Net cash used in operating activities		(3,534)	(1,169)
CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchase of property and equipment		(8)	(8)
Purchase of investment accounted for using the equity method (see note 3.a)		(98)	(2,993)
Purchase of intangible asset (see note 5)		(330)	(1,682)
Net cash used in investing activities		(436)	(4,683)
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES:
Short term loan repaid			(86)
Issuance of ordinary shares, pre-funded warrants and warrants, net		6,255
Net cash from (used in) financing activities		6,255	(86)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		2,285	(5,938)
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD		535	8,137
LOSSES FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS		(5)	(46)
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD		2,815	2,153
Supplemental disclosure of cash flow information:
Taxes paid		92	28
Interest paid			2
Supplemental disclosure of noncash investing and financing activities:
Issuance of ordinary shares to SciSparc Ltd. in consideration for ordinary shares (see note 3.b)			288
Consideration payable to sellers of Fort Products Ltd. included in other payables			349
Consideration payable to seller of SciSparc Nutraceuticals Inc. shares included in other payables			$ 41
[1] Except share and per share information

v3.24.3

General Information	6 Months Ended
	Jun. 30, 2024
General Information [Abstract]
GENERAL INFORMATION	NOTE 1 — GENERAL INFORMATION   a. General   Jeffs’ Brands Ltd (the “Company” or “Jeffs’ Brands”) was incorporated in Israel on March 7, 2021. As of September 30, 2024, the Company has five wholly owned subsidiaries — Smart Repair Pro (“Smart Pro”), Top Rank Ltd. (“Top Rank”), Jeffs’ Brands Holdings Inc. (“Jeffs’ Brands Holdings”), Fort Products Ltd. (“Fort”) and Fort Products LLC (“Fort US”), and together with Smart Pro, Top Rank and Jeffs’ Brands Holdings, the “Subsidiaries”). The Company and the Subsidiaries (“Group”) are engaged in the acquisition, improvement and operation of virtual stores (the “Brands”) mainly on the Amazon marketplace (“Amazon”) website.   References to the Company hereinafter, unless the context otherwise provides, include Jeffs’ Brands and the Subsidiaries on a consolidated basis.   Smart Pro, a corporation incorporated under the laws of the State of California, was established on December 20, 2017, and commenced its operations in June 2019. As of June 30, 2024, Smart Pro operated four Brands on the Amazon website.   In April 2021, Top Rank, an Israeli company, was incorporated as a wholly owned subsidiary of Jeffs’ Brands.   On February 23, 2023, Jeffs’ Brands Holdings was incorporated and registered under the laws of the State of Delaware as a wholly owned subsidiary of Jeffs’ Brands.   On February 23, 2023, the Company purchased approximately 49% of the issued and outstanding shares of SciSparc Nutraceuticals Inc. (“SciSparc U.S.”). For additional information see note 3a.   On March 9, 2023, the Company purchased all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales. For additional information see note 5.   On April 23, 2023, Fort US was incorporated and registered under the laws of the State of Delaware as a wholly owned subsidiary of Jeffs’ Brands Holdings.   b. Concentration Risk   The Group’s activities are mainly conducted through Amazon’s commercial platform. Any material change, whether temporary or permanent, including changes in Amazon’s terms of use and/or its policies, may affect sales performance, and may have a material effect on the Group’s financial position and the results of its operations.   In addition, the Group is engaged with a small number of suppliers as part of the production process of its brands. Any material changes in the supply process, whether temporary or permanent, may affect sales performance, and may have a material effect on the Group’s financial position and the results of its operations.   c. Liquidity   During the six months ended June 30, 2024, the Group incurred a net loss of $3,875 thousand and cash flows used in operating activities were $ 3,534 thousand. As of June 30, 2024, the Group had an accumulated deficit of approximately $12,151 thousand.   The Group intends to continue to finance its operating activities through the sale of products via the Brands and through raising additional capital, as needed.   On January 29, 2024, the Company completed a private placement transaction (the “Private Placement”), pursuant to a Securities Purchase Agreement with certain institutional investors for aggregate gross proceeds of approximately $7.275 million, before deduction of fees to the placement agent and other expenses payable by the Company in connection with the Private Placement. For additional information see note 4.a.   The Company’s negative cash flow from operations resulted, among other things, from purchase of inventory of $4,001 thousand during the six months period ended June 30, 2024. While the Company generated negative cash flow from operations during the six months ended June 30, 2024, the Company’s management believes that its current cash resources of $1.53 million, together with the realization of inventory in the near future will generate sufficient cash flow for the Company to carry out its operations during the 12 months from September 30, 2024, the date of issuance of these financial statements.

v3.24.3

Basis of Presentation and Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Basis of Presentation and Significant Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 — BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES   a. Unaudited Interim Financial Statements   The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included (consisting only of normal recurring adjustments except as otherwise discussed). For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 20-F for the year ended December 31, 2023.   b. Principles of Consolidation   The accompanying condensed consolidated financial statements include the accounts of the Group. All intercompany balances and transactions have been eliminated in consolidation.   c. Use of estimates   The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, derivative liability, useful lives of intangible assets, intangible assets impairment as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.   In the preparation of these condensed consolidated financial statements, the significant judgments exercised by management in the application of the Group’s accounting policies and the uncertainty involved in the key sources of those estimates were identical to the ones used in the Group’s consolidated financial statements for the year ended December 31, 2023.   d. Significant Accounting Policies   The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the Group’s financial statements for the year ended December 31, 2023.     e. Recent Accounting Pronouncements not yet adopted   In December 2023, the Financial Accounting Standards Board (the “FASB”) issued an Accounting Standards Update (“ASU”) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The ASU also includes other changes to improve the effectiveness of income tax disclosures, including further disaggregation of income taxes paid for individually significant jurisdictions. This ASU is effective for annual periods beginning after December 15, 2024. Adoption of this ASU should be applied on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.   In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker (“CODM”) and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. The ASU also allows, in addition to the measure that is most consistent with U.S. GAAP, the disclosure of additional measures of segment profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources. The ASU is effective for the Company’s Annual Report on Form 20F for the fiscal year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

v3.24.3

Investment in Affiliate	6 Months Ended
	Jun. 30, 2024
Investment in Affiliate [Abstract]
INVESTMENT IN AFFILIATE	NOTE 3 — INVESTMENT IN AFFILIATE     a. On February 23, 2023, the Company and Jeffs’ Brands Holdings entered into a stock purchase agreement (as amended on March 22, 2023, the “Wellution Agreement”), with SciSparc Ltd. (“SciSparc”), pursuant to which, on March 22, 2023, Jeffs’ Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc U.S., a wholly-owned subsidiary of SciSparc that owns and operates Wellution, an Amazon food supplements and cosmetics brand, representing approximately 49% of the issued and outstanding common stock of SciSparc U.S., for approximately $3.0 million in cash. The Company reviewed the transaction and deemed it to be the purchase of assets for accounting purposes under ASC Subtopic 805 “Business Combinations” (“ASC 805”), and not as a business combination. The Company reviewed the guidance under ASC 805 for the transaction and determined that the fair value of the gross assets acquired was concentrated in a single identifiable asset, a brand.   In connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S. (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. On September 4, 2024, the Company and SciSparc U.S. entered into an amendment to the SciSparc Consulting Agreement. Pursuant to the amendment to the SciSparc Consulting Agreement, the monthly fee was reduced to $10 thousand beginning on November 2023.   Jeffs’ Brands Holdings owns 49% of the voting rights in SciSparc U.S and has the right to appoint two out of five directors. Management has determined that it has significant influence over SciSparc U.S and accordingly accounts for its investment under the equity method.    The Company did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by ASC 805, Business Combinations.   The activity in the investment accounted for using the equity method was as follows:       January 1, 2024 – June 30, 2024       USD in thousands   Balance as of January 1, 2024     1,940   Equity losses     (245 ) Balance as of June 30, 2024     1,695     Summarized financial information:   Summarized statement of operations:       January 1, 2024 – June 30, 2024     February 23, 2023 – June 30, 2023       USD in thousands   Revenues     840       1,186   Net loss     (500 )     (151 )     b. Pursuant to the Wellution Agreement, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company issued 35,345 ordinary shares, no par value per share (“Ordinary Shares”) to SciSparc and SciSparc issued 13,858 (after giving effect to a 1-for-26 reverse share split effected by SciSparc on September 28, 2023), of its ordinary shares to the Company in a share exchange (collectively, the “Exchange Shares”), representing approximately 2.97% and 4.99%, respectively, of the Company’s and SciSparc’s issued and outstanding ordinary shares. The number of Exchange Shares acquired by each company was calculated by dividing $288 thousand by the average closing price of the relevant company’s shares on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third trading day immediately prior to the closing.   The investment in SciSparc was accounted for as financial asset through profit and loss.   The activity in investment at fair value was as follows:       January 1, 2024 – June 30, 2024       USD in thousands   Balance as of January 1, 2024     67   Revaluation losses     (56 ) Balance as of June 30, 2024     11

v3.24.3

Significant Events During the Period	6 Months Ended
	Jun. 30, 2024
Significant Events During the Period [Abstract]
SIGNIFICANT EVENTS DURING THE PERIOD	NOTE 4 — SIGNIFICANT EVENTS DURING THE PERIOD     a. On January 25, 2024, the Company entered into a Securities Purchase Agreement with certain institutional investors for aggregate gross proceeds of $7.275 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the Private Placement. The Private Placement closed on January 29, 2024 (“Issuance Date”).   As part of the Securities Purchase Agreement, the Company issued an aggregate of (i) 1,884,461 Ordinary Shares; (ii) Pre-Funded Warrants to purchase up to 820,000 Ordinary Shares at an exercise price of $0.00001 per Ordinary Share; (iii) Series A Warrants to purchase up to 3,380,586 Ordinary Shares at an exercise price of $2.69 per Ordinary Share (subject to certain anti-dilution and share combination event protections) and have a term of sixty-six (66) months from the date of issuance; and (iv) Series B Warrants to purchase, upon the satisfaction of certain conditions, up to 7,994,181 Ordinary Shares at an exercise price of $0.00001 Ordinary Share (following the end of an adjustment period as further described below). The Pre-Funded Warrants are exercisable as of the date of the issuance and will not expire until exercised in full.   L.I.A. Pure Capital Ltd. (“Pure Capital”) participated in the private placement as a purchaser and purchased securities in the amount of $300 thousand. see note 9.c.2.   The number of Ordinary Shares issuable under the Series A and Series B Warrant was subject to an adjustment determined by the trading price of the Ordinary Shares following the effectiveness of a resale registration statement (the “Resale Registration Statement”) (see below) that the Company undertook to file, subject to a pricing floor of $0.68 per Ordinary Share. Pursuant to such, the maximum number of Ordinary Shares underlying each of the Series A and Series B Warrants would have been an aggregate of 13,373,177 Ordinary Shares and 7,994,181 Ordinary Shares, respectively.   Following the effectiveness of the Resale Registration Statement, on March 11, 2024 (i) Series A Warrants are exercisable into a total number of 13,373,177 Ordinary Shares (subject to certain anti-dilution and share combination event protections) and have an exercise price of $0.68 per Ordinary Share; and (ii) Series B Warrants are exercisable into a total number of 7,904,181 Ordinary Shares at an exercise price of per Ordinary Share $0.00001, following the adjustment. Subsequent to such adjustment, the Series B Warrants have a term of sixty-six (66) months from the date of issuance.   As of the date of these consolidated financial statements, pre-funded warrants to purchase 820,000 Ordinary Shares and Series B Warrants to purchase 5,257,127 Ordinary Shares were exercised for an aggregate issuance of 6,077,127 Ordinary Shares.   In connection with the Private Placement, the Company also entered into a placement agent agreement (the “Placement Agent Agreement”) with Aegis Capital Corp. (“Aegis”) dated January 25, 2024, pursuant to which Aegis agreed to serve as the exclusive placement agent for the Company in connection with the Private Placement. The Company agreed to pay Aegis a cash placement fee equal to 8.50% of the gross cash proceeds received in the Private Placement and to pay for expenses of the purchasers’ and Aegis’ legal counsel up to an aggregate amount of $90 thousand.     b. On April 25, 2024, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”), notifying that the Company was not in compliance with the minimum bid price requirement for continued listing on Nasdaq, as set forth under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), because the closing bid price of the Ordinary Shares was below $1.00 per Ordinary Share for the previous 30 consecutive business days. The Company was granted 180 calendar days, or until October 22, 2024, to regain compliance with the Minimum Bid Price Requirement. The Company can regain compliance if, at any time during this 180-day period, the closing bid price of the Company’s Ordinary Shares is at least $1.00 for a minimum of ten consecutive business days.   In the event that the Company does not regain compliance after the initial 180-day period, the Company may then be eligible for an additional 180-day compliance period if the Company meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for Nasdaq.

v3.24.3

Intangible Assets	6 Months Ended
	Jun. 30, 2024
Intangible Assets [Abstract]
INTANGIBLE ASSETS	NOTE 5 — INTANGIBLE ASSETS    Total intangible assets consisted of the following as of June 30, 2024 and December 31, 2023:       June 30, 2024       Gross Amount     Accumulated Amortization     Net Balance       U.S. dollars in thousands   Brands     7,774       (2,444 )     5,330          December 31, 2023       Gross Amount     Accumulated Amortization     Net Balance       U.S. dollars in thousands   Brands     7,774       (2,060 )     5,714     Amortization expense was $384 thousand and $347 thousand, for the six months ended June 30, 2024, and 2023, respectively.     a. On March 2, 2023, the Company entered into a share purchase agreement (the “Fort SPA”), with the holders (the “Sellers”), of all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales and engaged in the sale of pest control products primarily through Amazon.uk, pursuant to which on March 9, 2023, the Company acquired all of the issued and outstanding share capital of Fort, for approximately £2 million (approximately $2.4 million) (the “Fort Acquisition”).   On February 29, 2024, the Company entered into a side letter to the Fort SPA with the Sellers, pursuant to which the Company agreed to increase certain adjustment amount payments to the Sellers by approximately £100 thousand (approximately $128 thousand).    On March 9, 2023, the Company recognized the amount of $1,991 thousand paid in connection with the Fort Acquisition amortized over a period of ten (10) years.   As part of the Fort SPA, the employment of these employees was terminated within three months, with all termination costs to be borne by the Sellers.    Also, in connection with the closing of the Fort Acquisition, on March 9, 2023, Fort and the Sellers entered into a consulting agreement, pursuant to which the Sellers will provide the Company with consultancy services for a period of six months following the closing, at a monthly fee of £2.5 thousand (approximately $3 thousand). On September 20, 2023, the Company and the Sellers entered into a new consulting agreement for indefinite period at a monthly fee of £3.5 thousand (approximately $4.5 thousand) effective as of June 1, 2023 (the “Fort Consulting Agreement”). On July 9, 2024 the Fort Consulting Agreement was terminated.   The Company did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by ASC 805, Business Combinations.

v3.24.3

Other Payables	6 Months Ended
	Jun. 30, 2024
Other Payables [Abstract]
OTHER PAYABLES	NOTE 6 — OTHER PAYABLES       June 30, 2024     December 31, 2023       USD in thousands   Government institutions     561       428   Employees and related benefits     120       85   Operating lease liabilities     69       82   Liability to sellers     -       (*)430   Revenue Sharing Payment payable     141       140   Accrued expenses and other payables     402       368         1,293       1,533      (*) Includes $98 thousand to SciSparc as of December 31, 2023. See Note 9 for additional information.

v3.24.3

Derivative Liabilities	6 Months Ended
	Jun. 30, 2024
Derivative Liabilities [Abstract]
DERIVATIVE LIABILITIES	NOTE 7 — DERIVATIVE LIABILITIES   Additional Warrants   On November 28, 2022, the Company issued additional warrants (the “Additional Warrants”), following certain adjustments pursuant to the terms of the warrants issued as part of the Company’s Initial Public Offering (the “IPO Warrants”), to purchase up to 403,504 Ordinary Shares to certain qualified buyers, as defined in the IPO Warrants. The term of each Additional Warrant is five years from the issuance date. Each Additional Warrant holder receives semi-annual payments equal to approximately 2.3% of the Company’s gross revenues, calculated for the first and second six-month fiscal periods, shared pro rata among qualified holders (“Revenue Sharing Payment”). As of June 30, 2024, the Revenue Sharing Payment was equal to approximately 2.3% of the Company’s revenues for the six months ended June 30, 2024. The Company determined that the Additional Warrants preclude equity classification due to the Revenue Sharing Payment feature. As such, the Additional Warrants were classified as a derivative liability. The derivative liability is recorded at fair value and amounted to $922 thousand as of June 30, 2024.   Additionally, the revenue forecast over the life of the Additional Warrants is a significant input in determining the price of the Additional Warrants as of June 30, 2024.   Series A Warrants   As part of the Private Placement, the Company issued Series A Warrants to purchase up to an aggregate of 3,380,586 Ordinary Shares at an exercise price of $2.69 per Ordinary Share (subject to certain anti-dilution and share combination event protections) as of the Issuance Date. Following effectiveness of the Resale Registration Statement, on March 11, 2024, the Series A Warrants are exercisable into an aggregate of 13,373,208 Ordinary Shares at an exercise price of $0.68 per Ordinary Share (subject to certain anti-dilution and share combination event protections). The Series A Warrants were immediately exercisable, and set to expire within sixty-six (66) months from the date of issuance. According to terms of the Series A Warrants, in an event of a Dilutive Issuance (as defined in the Series A Warrant) or a Share Combination Event (as defined in the Series A Warrant), if the lowest share price during the five consecutive trading days commencing on the date on which the Share Combination Event is effected is less than the exercise price per Ordinary Share (“Exercise Price”), and the total exercise price will be reduced and the number of Series A Warrant shares issuable hereunder shall be increased in such that the aggregate exercise price payable hereunder, after taking into account the decrease in the Exercise Price, shall be equal to the aggregate Exercise Price on the issue date.   The Company determined that the Series A Warrants preclude equity classification due to the anti-dilutive protection feature. As such, the Series A Warrants were classified as a derivative liability. The derivative liability is recorded at fair value and amounted to $5,484 thousand as of June 30, 2024. The following table presents changes in the fair value of the derivative Series A Warrants and the Additional Warrants liability during the period (in thousands)       Series A Warrants     Additional Warrants     Total                       Balance as of December 31, 2023     -       1,375       1,375   Issuance on January 29, 2024     4,301       -       4,301   Change in fair value     1,183       (453 )     730   Balance as of June 30, 2024     5,484       922       6,406     The following table lists the significant unobservable inputs used for calculation of fair value of the Additional Warrants:       June 30, 2024     December 31, 2023   Expected volatility     121.91 %     101.39 % Exercise price   $ 14.14       14.14   Share price   $ 0.30       3.05   Risk-free interest rate     4.47 %     3.93 % Dividend yield     -       -   Expected life     3.41       3.91   Weighted average cost of capital (WACC)     20.7 %     20.4 %   The following table lists the significant unobservable inputs used for calculation of fair value of Series A Warrants:       June 30, 2024   Expected volatility     125.6 % Exercise price   $ 0.68   Share price   $ 0.30   Risk-free interest rate     4.33 % Dividend yield     -   Expected life     5.08

v3.24.3

Financial Expenses (Income), Net	6 Months Ended
	Jun. 30, 2024
Financial Expenses (Income), Net [Abstract]
FINANCIAL EXPENSES (INCOME), NET	NOTE 8 — FINANCIAL EXPENSES (INCOME), NET       Six months ended June 30,       2024     2023       U.S. dollars in thousands                 Change in fair value of derivative liabilities     730       (341 ) Exchange rate differences     20       102   Interest income     (60 )     (4 ) Issuance costs of financial instruments classified as derivative liabilities     603       -   Revaluation of securities -fair value through profit or loss     57       90   Other finance expenses     17       5         1,367       (148 )

v3.24.3

Related Parties — Transactions and Balances	6 Months Ended
	Jun. 30, 2024
Related Parties — Transactions and Balances [Abstract]
RELATED PARTIES — TRANSACTIONS AND BALANCES	NOTE 9 — RELATED PARTIES — TRANSACTIONS AND BALANCES   a. Transactions with interested and related parties:       Six months ended June 30,       2024     2023       U.S. dollars in thousands   Labor cost and related expenses (included in general and administrative) (c1)     140       133   Inventory storage (included in cost of sale) (c2)     207       313   Consulting fees (included in general and administrative) (c2)     78       95   Consulting fees (included in general and administrative) (c3)     120       -   Other income (c4)     (60 )     (158 ) Revenue Sharing Payment (included in general and administrative) (c5)     21       19         506       402       b. Balances with interested and related parties:       Period ended       June 30, 2024     December 31, 2023       U.S. dollars in thousands   ASSETS:             Related parties (c4)     53       -         53       -   LIABILITIES:                 Related parties (c7)     31       66   Chief executive officer salary (included in other account payable) (c1)     19       18   Revenue Sharing Payment (included in other account payable) (c5)     21       21   Liability to SciSparc (included in other account payable) (c6)     -       98   Liability to Xylo (included in other account payable) (c3)     20       -   Liability to supplier (included in trade payable) (c2)     33       69   Liability to consultant (included in other account payable and trade payable) (c2)     18       17         142       289      c. Additional information:   1. The Company's chief executive officer monthly salary is NIS 80 thousand (approximately $21 thousand) plus VAT.   2. On October 26, 2022, the Company and Pure Capital entered into a consulting agreement (the “Pure Capital Consulting Agreement”) pursuant to which Pure Capital will provide consultancy services to the Company for a monthly fee of NIS 57.75 thousand (approximately $16 thousand). Pursuant to the Pure Capital Consulting Agreement, Pure Capital is also entitled during the term of the Pure Capital Consulting Agreement to the following payments: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding, and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the board of directors based on the Pure Capital Consulting Agreement. In March 2023, the Company paid Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration for the investments in Fort and SciSparc. Additionally, on October 26, 2022, the Company and Pure NJ Logistics LLC, a company wholly-owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in New Jersey.   On February 5, 2024, the Company paid Pure Capital $100 thousand pursuant to the terms of Pure Capital Consulting Agreement in connection with the Company’s initial public offering.   On September, 4, 2024, the Company and Pure Capital signed an amendment to the Pure Capital Consulting Agreement. According to the amendment Pure Capital will be entitled to a special bonus upon the consummation of an offering of securities of the Company, including proceeds received from exercise of warrants issued, according to the below distribution, which is based on gross proceeds: (i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company.   3. On April 30, 2024, the Company entered into a consulting agreement (the “Xylo Consulting Agreement”) with Xylo Technologies Ltd. (formerly Medigus Ltd) (“Xylo”), pursuant to which Xylo will provide consultancy services to the Company for a monthly fee of $20 thousand. The Xylo Consulting Agreement is for a period of thirty-six (36) months beginning January 2024 and may be terminated for cause with thirty (30) days advance notice. The consultancy services fees paid according to the Xylo Consulting Agreement are included in other expenses.     4. On March 22, 2023, the Company entered into a consulting agreement with SciSparc (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. In November 2023 the monthly fee was reduced to $10 thousand. The consultancy services fees paid pursuant to the SciSparc Consulting Agreement are included in other income in the condensed consolidated statements of operations.   5. In April 2024, the Company paid $12 thousand to Xylo and $9 thousand to Pure Capital in connection to Revenue Sharing Payment. The outstanding payable to Xylo and Pure Capital as of June 30, 2024, is $12 thousand and $9 thousand, respectively.   6. The outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand. This amount was paid on January 31, 2024.   7. During the six months ended June 30, 2024 the Company paid to Xylo $25 thousand in connection with the outstanding payable amount related to Xylo employee services provided to the Company.

v3.24.3

Subsequent Events	6 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 — SUBSEQUENT EVENTS     a. On July 1, 2024, Fort entered into a lease agreement for a new warehouse in the UK. The lease agreement is for a period of five years and the annual rent fees £52,000.         b. On July 17, 2024, the shareholders of the Company approved at the annual general meeting the following:  (i) the re-election of the directors Liron Carmel and Eliyahu Yoresh until the close of the annual general meeting to be held in 2027, or earlier by resignation or removal, as applicable, (ii) the adoption of a new compensation policy for the Company’s executive officers and directors, (iii) the amendment to the articles of association of the Company, adoption of new compensation terms to each of the chairman and the chief executive officer of the Company, (iv) a reverse split of the Company’s issued and outstanding Ordinary Shares in a range between 1:2 and 1:22, to be affected at the discretion of, and at such ratio and on such date to be determined by, the board of directors and (v) the re-appointment of Brightman Almagor Zohar & Co., a firm in the Deloitte Global Network, as the Company’s independent registered public accounting firm for the year ending December 31, 2024 and until the next annual general meeting of shareholders.

v3.24.3

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2024
Basis of Presentation and Significant Accounting Policies [Abstract]
Unaudited Interim Financial Statements	a. Unaudited Interim Financial Statements The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included (consisting only of normal recurring adjustments except as otherwise discussed). For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 20-F for the year ended December 31, 2023.
Principles of Consolidation	b. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Group. All intercompany balances and transactions have been eliminated in consolidation.
Use of estimates	c. Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, derivative liability, useful lives of intangible assets, intangible assets impairment as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates. In the preparation of these condensed consolidated financial statements, the significant judgments exercised by management in the application of the Group’s accounting policies and the uncertainty involved in the key sources of those estimates were identical to the ones used in the Group’s consolidated financial statements for the year ended December 31, 2023.
Significant Accounting Policies	d. Significant Accounting Policies The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the Group’s financial statements for the year ended December 31, 2023.
Recent Accounting Pronouncements not yet adopted	e. Recent Accounting Pronouncements not yet adopted In December 2023, the Financial Accounting Standards Board (the “FASB”) issued an Accounting Standards Update (“ASU”) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The ASU also includes other changes to improve the effectiveness of income tax disclosures, including further disaggregation of income taxes paid for individually significant jurisdictions. This ASU is effective for annual periods beginning after December 15, 2024. Adoption of this ASU should be applied on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker (“CODM”) and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. The ASU also allows, in addition to the measure that is most consistent with U.S. GAAP, the disclosure of additional measures of segment profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources. The ASU is effective for the Company’s Annual Report on Form 20F for the fiscal year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

v3.24.3

Investment in Affiliate (Tables)	6 Months Ended
	Jun. 30, 2024
Investment in Affiliate [Abstract]
Schedule of Equity Method	The activity in the investment accounted for using the equity method was as follows:     January 1, 2024 – June 30, 2024       USD in thousands   Balance as of January 1, 2024     1,940   Equity losses     (245 ) Balance as of June 30, 2024     1,695
Schedule of Statement of Operations	Summarized statement of operations:     January 1, 2024 – June 30, 2024     February 23, 2023 – June 30, 2023       USD in thousands   Revenues     840       1,186   Net loss     (500 )     (151 )
Schedule of Activity in Investment at Fair Value	The activity in investment at fair value was as follows:     January 1, 2024 – June 30, 2024       USD in thousands   Balance as of January 1, 2024     67   Revaluation losses     (56 ) Balance as of June 30, 2024     11

v3.24.3

Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2024
Intangible Assets [Abstract]
Schedule of Intangible Assets	Total intangible assets consisted of the following as of June 30, 2024 and December 31, 2023:     June 30, 2024       Gross Amount     Accumulated Amortization     Net Balance       U.S. dollars in thousands   Brands     7,774       (2,444 )     5,330       December 31, 2023       Gross Amount     Accumulated Amortization     Net Balance       U.S. dollars in thousands   Brands     7,774       (2,060 )     5,714

v3.24.3

Other Payables (Tables)	6 Months Ended
	Jun. 30, 2024
Other Payables [Abstract]
Schedule of Other Payables	June 30, 2024     December 31, 2023       USD in thousands   Government institutions     561       428   Employees and related benefits     120       85   Operating lease liabilities     69       82   Liability to sellers     -       (*)430   Revenue Sharing Payment payable     141       140   Accrued expenses and other payables     402       368         1,293       1,533   (*) Includes $98 thousand to SciSparc as of December 31, 2023. See Note 9 for additional information.

v3.24.3

Derivative Liabilities (Tables)	6 Months Ended
	Jun. 30, 2024
Derivative Liabilities [Abstract]
Schedule of Fair Value of the Derivative Series A Warrants and the Additional Warrants Liability	The following table presents changes in the fair value of the derivative Series A Warrants and the Additional Warrants liability during the period (in thousands)     Series A Warrants     Additional Warrants     Total                       Balance as of December 31, 2023     -       1,375       1,375   Issuance on January 29, 2024     4,301       -       4,301   Change in fair value     1,183       (453 )     730   Balance as of June 30, 2024     5,484       922       6,406
Schedule of Fair Value of the Additional Warrants	The following table lists the significant unobservable inputs used for calculation of fair value of the Additional Warrants:     June 30, 2024     December 31, 2023   Expected volatility     121.91 %     101.39 % Exercise price   $ 14.14       14.14   Share price   $ 0.30       3.05   Risk-free interest rate     4.47 %     3.93 % Dividend yield     -       -   Expected life     3.41       3.91   Weighted average cost of capital (WACC)     20.7 %     20.4 % The following table lists the significant unobservable inputs used for calculation of fair value of Series A Warrants:     June 30, 2024   Expected volatility     125.6 % Exercise price   $ 0.68   Share price   $ 0.30   Risk-free interest rate     4.33 % Dividend yield     -   Expected life     5.08

v3.24.3

Financial Expenses (Income), Net (Tables)	6 Months Ended
	Jun. 30, 2024
Financial Expenses (Income), Net [Abstract]
Schedule of Financial Expenses (Income), Net	Six months ended June 30,       2024     2023       U.S. dollars in thousands                 Change in fair value of derivative liabilities     730       (341 ) Exchange rate differences     20       102   Interest income     (60 )     (4 ) Issuance costs of financial instruments classified as derivative liabilities     603       -   Revaluation of securities -fair value through profit or loss     57       90   Other finance expenses     17       5         1,367       (148 )

v3.24.3

Related Parties — Transactions and Balances (Tables)	6 Months Ended
	Jun. 30, 2024
Related Parties — Transactions and Balances [Abstract]
Schedule of Transactions with Interested and Related Parties	Transactions with interested and related parties:     Six months ended June 30,       2024     2023       U.S. dollars in thousands   Labor cost and related expenses (included in general and administrative) (c1)     140       133   Inventory storage (included in cost of sale) (c2)     207       313   Consulting fees (included in general and administrative) (c2)     78       95   Consulting fees (included in general and administrative) (c3)     120       -   Other income (c4)     (60 )     (158 ) Revenue Sharing Payment (included in general and administrative) (c5)     21       19         506       402   1. The Company's chief executive officer monthly salary is NIS 80 thousand (approximately $21 thousand) plus VAT.   2. On October 26, 2022, the Company and Pure Capital entered into a consulting agreement (the “Pure Capital Consulting Agreement”) pursuant to which Pure Capital will provide consultancy services to the Company for a monthly fee of NIS 57.75 thousand (approximately $16 thousand). Pursuant to the Pure Capital Consulting Agreement, Pure Capital is also entitled during the term of the Pure Capital Consulting Agreement to the following payments: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding, and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the board of directors based on the Pure Capital Consulting Agreement. In March 2023, the Company paid Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration for the investments in Fort and SciSparc. Additionally, on October 26, 2022, the Company and Pure NJ Logistics LLC, a company wholly-owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in New Jersey. On February 5, 2024, the Company paid Pure Capital $100 thousand pursuant to the terms of Pure Capital Consulting Agreement in connection with the Company’s initial public offering. On September, 4, 2024, the Company and Pure Capital signed an amendment to the Pure Capital Consulting Agreement. According to the amendment Pure Capital will be entitled to a special bonus upon the consummation of an offering of securities of the Company, including proceeds received from exercise of warrants issued, according to the below distribution, which is based on gross proceeds: (i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company. 3. On April 30, 2024, the Company entered into a consulting agreement (the “Xylo Consulting Agreement”) with Xylo Technologies Ltd. (formerly Medigus Ltd) (“Xylo”), pursuant to which Xylo will provide consultancy services to the Company for a monthly fee of $20 thousand. The Xylo Consulting Agreement is for a period of thirty-six (36) months beginning January 2024 and may be terminated for cause with thirty (30) days advance notice. The consultancy services fees paid according to the Xylo Consulting Agreement are included in other expenses.   4. On March 22, 2023, the Company entered into a consulting agreement with SciSparc (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. In November 2023 the monthly fee was reduced to $10 thousand. The consultancy services fees paid pursuant to the SciSparc Consulting Agreement are included in other income in the condensed consolidated statements of operations.   5. In April 2024, the Company paid $12 thousand to Xylo and $9 thousand to Pure Capital in connection to Revenue Sharing Payment. The outstanding payable to Xylo and Pure Capital as of June 30, 2024, is $12 thousand and $9 thousand, respectively.
Schedule of Balances with Interested and Related Parties	Balances with interested and related parties:     Period ended       June 30, 2024     December 31, 2023       U.S. dollars in thousands   ASSETS:             Related parties (c4)     53       -         53       -   LIABILITIES:                 Related parties (c7)     31       66   Chief executive officer salary (included in other account payable) (c1)     19       18   Revenue Sharing Payment (included in other account payable) (c5)     21       21   Liability to SciSparc (included in other account payable) (c6)     -       98   Liability to Xylo (included in other account payable) (c3)     20       -   Liability to supplier (included in trade payable) (c2)     33       69   Liability to consultant (included in other account payable and trade payable) (c2)     18       17         142       289   1. The Company's chief executive officer monthly salary is NIS 80 thousand (approximately $21 thousand) plus VAT.   2. On October 26, 2022, the Company and Pure Capital entered into a consulting agreement (the “Pure Capital Consulting Agreement”) pursuant to which Pure Capital will provide consultancy services to the Company for a monthly fee of NIS 57.75 thousand (approximately $16 thousand). Pursuant to the Pure Capital Consulting Agreement, Pure Capital is also entitled during the term of the Pure Capital Consulting Agreement to the following payments: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding, and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the board of directors based on the Pure Capital Consulting Agreement. In March 2023, the Company paid Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration for the investments in Fort and SciSparc. Additionally, on October 26, 2022, the Company and Pure NJ Logistics LLC, a company wholly-owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in New Jersey. On February 5, 2024, the Company paid Pure Capital $100 thousand pursuant to the terms of Pure Capital Consulting Agreement in connection with the Company’s initial public offering. On September, 4, 2024, the Company and Pure Capital signed an amendment to the Pure Capital Consulting Agreement. According to the amendment Pure Capital will be entitled to a special bonus upon the consummation of an offering of securities of the Company, including proceeds received from exercise of warrants issued, according to the below distribution, which is based on gross proceeds: (i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company. 3. On April 30, 2024, the Company entered into a consulting agreement (the “Xylo Consulting Agreement”) with Xylo Technologies Ltd. (formerly Medigus Ltd) (“Xylo”), pursuant to which Xylo will provide consultancy services to the Company for a monthly fee of $20 thousand. The Xylo Consulting Agreement is for a period of thirty-six (36) months beginning January 2024 and may be terminated for cause with thirty (30) days advance notice. The consultancy services fees paid according to the Xylo Consulting Agreement are included in other expenses.   4. On March 22, 2023, the Company entered into a consulting agreement with SciSparc (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. In November 2023 the monthly fee was reduced to $10 thousand. The consultancy services fees paid pursuant to the SciSparc Consulting Agreement are included in other income in the condensed consolidated statements of operations.   5. In April 2024, the Company paid $12 thousand to Xylo and $9 thousand to Pure Capital in connection to Revenue Sharing Payment. The outstanding payable to Xylo and Pure Capital as of June 30, 2024, is $12 thousand and $9 thousand, respectively. 6. The outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand. This amount was paid on January 31, 2024. 7. During the six months ended June 30, 2024 the Company paid to Xylo $25 thousand in connection with the outstanding payable amount related to Xylo employee services provided to the Company.

v3.24.3

General Information (Details) - USD ($) $ in Thousands				6 Months Ended
		Jan. 29, 2024	Feb. 23, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
General Information [Line Items]
Date of incorporation				Mar. 07, 2021
Purchase of issued and outstanding shares percentage			49.00%
Net loss	[1]			$ (3,875)	$ (1,828)
Cash flows used in operating activities				(3,534)	$ (1,169)
Accumulated deficit				(12,151)		$ (8,276)
Aggregate gross proceeds		$ 7,275
Purchase of inventory				4,001
Current cash resources				$ 1,530
[1] Except share and per share information

v3.24.3

Investment in Affiliate (Details) - USD ($) $ / shares in Thousands, $ in Thousands				1 Months Ended	6 Months Ended
	Sep. 28, 2023	Mar. 22, 2023	Feb. 23, 2023	Nov. 30, 2023	Jun. 30, 2024	Dec. 31, 2023
Investment in Affiliate (Details) [Line Items]
Shares of common stock					9,177,100	1,215,512
Ordinary shares issued and outstanding, percentage		4.99%	49.00%
Fee amount				$ 10
Bonus amount					$ 51
Par value per share
Reverse share split	1-for-26
SciSparc Ltd [Member]
Investment in Affiliate (Details) [Line Items]
Shares of common stock		13,858	57
Ordinary shares issued and outstanding, percentage		2.97%
Cash			$ 3,000
Jeffs Brands Holding [Member]
Investment in Affiliate (Details) [Line Items]
Percentage of voting rights					49.00%
SciSparc Consulting Agreement [Member]
Investment in Affiliate (Details) [Line Items]
Fee amount				$ 10	$ 20
Wellution Agreement [Member]
Investment in Affiliate (Details) [Line Items]
Shares of common stock		35,345
Par value per share
Average closing price		$ 288

v3.24.3

Investment in Affiliate (Details) - Schedule of Equity Method - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Schedule Of Equity Method Abstract
Balance as of January 1, 2024		$ 1,940
Equity losses	[1]	(245)	$ (89)
Balance as of June 30, 2024		$ 1,695
[1] Except share and per share information

v3.24.3

Investment in Affiliate (Details) - Schedule of Statement of Operations - Wellution [Member] - USD ($) $ in Thousands	4 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2024
Condensed Income Statements, Captions [Line Items]
Revenues	$ 1,186	$ 840
Net loss	$ (151)	$ (500)

v3.24.3

Investment in Affiliate (Details) - Schedule of Activity in Investment at Fair Value $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($)
Schedule Of Activity In Investment At Fair Value Abstract
Balance as of January 1, 2024	$ 67
Revaluation losses	(56)
Balance as of June 30, 2024	$ 11

v3.24.3

Significant Events During the Period (Details) - USD ($) $ / shares in Units, $ in Thousands				6 Months Ended
	Apr. 25, 2024	Jan. 29, 2024	Jan. 25, 2024	Jun. 30, 2024	Mar. 11, 2024	Nov. 28, 2022
Significant Events During the Period [Line Items]
Gross proceeds (in Dollars)		$ 7,275
Issuance of ordinary shares				6,077,127
Warrant to purchase shares			7,994,181
Warrants term			66 months	66 months	66 months
Pricing floor (in Dollars per Share)			0.68
Percentage of gross cash proceeds				8.50%
Payment for legal expenses (in Dollars)				$ 90
Closing bid price per share (in Dollars per share)	$ 1
Pure Capital Ltd. [Member]
Significant Events During the Period [Line Items]
Purchased of private placement (in Dollars)				$ 300
Pre-Funded Warrants [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares			820,000	820,000
Exercise price of per share (in Dollars per share)			$ 0.00001
Series A Warrants [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares			3,380,586		13,373,177
Exercise price of per share (in Dollars per share)			$ 2.69	$ 0.68	$ 0.68
Series B Warrants [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares			7,994,181	5,257,127	7,904,181
Exercise price of per share (in Dollars per share)			$ 0.00001		$ 0.00001
Ordinary Shares [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares						403,504
Closing bid price per share (in Dollars per share)	$ 1
Private Placement [Member]
Significant Events During the Period [Line Items]
Gross proceeds (in Dollars)			$ 7,275
Issuance of ordinary shares			1,884,461
Private Placement [Member] | Series A Warrants [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares				3,380,586
Private Placement [Member] | Ordinary Shares [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares				2.69
Resale Registration Statement [Member] | Series A Warrants [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares			13,373,177

v3.24.3

Intangible Assets (Details)							6 Months Ended
	Feb. 29, 2024 USD ($)	Feb. 29, 2024 GBP (£)	Sep. 20, 2023 USD ($)	Sep. 20, 2023 GBP (£)	Mar. 09, 2023 USD ($)	Mar. 09, 2023 GBP (£)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Mar. 09, 2024 USD ($)	Mar. 09, 2023 GBP (£)
Intangible Assets (Details) [Line Items]
Amortization expense							$ 384,000	$ 347,000
Share capital outstanding (in Pounds) | £										£ 2,000,000
Payments to sellers | £		£ 100,000
Recognized amount									$ 1,991,000
Consultancy fee			$ 4,500	£ 3,500	$ 3,000	£ 2,500
Acquisition amortized					10 years					10 years
Fort Acquisition [Member]
Intangible Assets (Details) [Line Items]
Share capital issued					$ 2,400,000
Fort SPA [Member]
Intangible Assets (Details) [Line Items]
Payments to sellers	$ 128,000

v3.24.3

Intangible Assets (Details) - Schedule of Intangible Assets - Brands [Member] - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Schedule of Intangible Assets [Line Items]
Gross Amount	$ 7,774	$ 7,774
Accumulated Amortization	(2,444)	(2,060)
Net Balance	$ 5,330	$ 5,714

v3.24.3

Other Payables (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Other Payables [Abstract]
Other payables	$ 98

v3.24.3

Other Payables (Details) - Schedule of Other Payables - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Schedule of Other Payables [Abstract]
Government institutions	$ 561	$ 428
Employees and related benefits	120	85
Operating lease liabilities	69	82
Liability to sellers		430	[1]
Revenue Sharing Payment payable	141	140
Accrued expenses and other payables	402	368
Total	$ 1,293	$ 1,533
[1] Includes $98 thousand to SciSparc as of December 31, 2023. See Note 9 for additional information.

v3.24.3

Derivative Liabilities (Details) - USD ($) $ / shares in Units, $ in Thousands		6 Months Ended
	Nov. 28, 2022	Jun. 30, 2024	Mar. 11, 2024	Jan. 25, 2024
Derivative Liabilities [Line Items]
Purchase shares				7,994,181
Warrant term		66 months	66 months	66 months
Percentage of gross revenues	2.30%
Revenue sharing payment percentage		2.30%
Derivative liability (in Dollars)		$ 922
Additional Warrants [Member]
Derivative Liabilities [Line Items]
Warrant term	5 years
Series A Warrants [Member]
Derivative Liabilities [Line Items]
Purchase shares			13,373,177	3,380,586
Derivative liability (in Dollars)		$ 5,484
Number of warrants exercisable		13,373,208
Exercise price (in Dollars per share)		$ 0.68	$ 0.68	$ 2.69
Common Stock [Member]
Derivative Liabilities [Line Items]
Purchase shares	403,504
Private Placement [Member] | Series A Warrants [Member]
Derivative Liabilities [Line Items]
Purchase shares		3,380,586
Private Placement [Member] | Common Stock [Member]
Derivative Liabilities [Line Items]
Purchase shares		2.69

v3.24.3

Derivative Liabilities (Details) - Schedule of Fair Value of the Derivative Series A Warrants and the Additional Warrants Liability - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Schedule of Fair Value of the Derivative Series A Warrants and the Additional Warrants Liability [Line Items]
Balance at beginning	$ 1,375
Issuance on January 29, 2024	4,301
Change in fair value	730	$ (341)
Balance at ending	6,406
Series A Warrants [Member]
Schedule of Fair Value of the Derivative Series A Warrants and the Additional Warrants Liability [Line Items]
Balance at beginning
Issuance on January 29, 2024	4,301
Change in fair value	1,183
Balance at ending	5,484
Additional Warrants [Member]
Schedule of Fair Value of the Derivative Series A Warrants and the Additional Warrants Liability [Line Items]
Balance at beginning	1,375
Issuance on January 29, 2024
Change in fair value	(453)
Balance at ending	$ 922

v3.24.3

Derivative Liabilities (Details) - Schedule of Fair Value of the Additional Warrants	Jun. 30, 2024	Jun. 30, 2023
Expected volatility [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	121.91	101.39
Expected volatility [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	125.6
Exercise price [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	14.14	14.14
Exercise price [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	0.68
Share price [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	0.3	3.05
Share price [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	0.3
Risk-free interest rate [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	4.47	3.93
Risk-free interest rate [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	4.33
Dividend yield [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability
Dividend yield [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability
Expected life [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	3.41	3.91
Expected life [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	5.08
Weighted average cost of capital (WACC) [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	20.7	20.4

v3.24.3

Financial Expenses (Income), Net (Details) - Schedule of Financial Expenses (Income), Net - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Schedule of Financial Expenses (Income), Net [Abstract]
Change in fair value of derivative liabilities		$ 730	$ (341)
Exchange rate differences		20	102
Interest income		(60)	(4)
Issuance costs of financial instruments classified as derivative liabilities		603
Revaluation of securities -fair value through profit or loss		57	90
Other finance expenses		17	5
Total	[1]	$ 1,367	$ (148)
[1] Except share and per share information

v3.24.3

Related Parties — Transactions and Balances (Details) $ in Thousands					1 Months Ended					6 Months Ended
	Apr. 30, 2024 USD ($)	Feb. 05, 2024 USD ($)	Jan. 31, 2024 USD ($)	Mar. 22, 2023 USD ($)	Apr. 30, 2024 USD ($)	Nov. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Oct. 26, 2022 USD ($)	Oct. 26, 2022 ILS (₪)	Jun. 30, 2024 USD ($)	Jun. 30, 2024 ILS (₪)	Jun. 30, 2023 USD ($)
Related Parties — Transactions and Balances [Line Items]
Consultancy services fees	$ 20							$ 16	₪ 57,750
Percentage of gross proceed								7.00%	7.00%
Percentage of total consideration paid								8.00%	8.00%
Paid to pure capital							$ 352
Payment to related party										$ 506		$ 402
Related party transaction, description										(i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company.	(i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company.
Bonus amount				$ 51
Advance Notice Period	30 years			30 days
Monthly fee						$ 10
Outstanding payable related to employee services										$ 25
Consulting agreement, term	36 days
Pure Capital Ltd. [Member]
Related Parties — Transactions and Balances [Line Items]
Related party, debts					$ 9
Outstanding payable										9
SciSparc Consulting Agreement [Member]
Related Parties — Transactions and Balances [Line Items]
Consultancy services fees				$ 20
Amount of outstanding due			$ 98
Xylo Technologies Ltd [Member]
Related Parties — Transactions and Balances [Line Items]
Related party, debts					$ 12
Outstanding payable										12
Chief Executive Officer [Member]
Related Parties — Transactions and Balances [Line Items]
Monthly salary										$ 21	₪ 80,000
IPO [Member] | Pure Capital Ltd. [Member]
Related Parties — Transactions and Balances [Line Items]
Payment to related party		$ 100

v3.24.3

Related Parties — Transactions and Balances (Details) - Schedule of Transactions with Interested and Related Parties - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Schedule of Transactions with Interested and Related Parties [Abstract]
Labor cost and related expenses (included in general and administrative) (c1)	[1]	$ 140	$ 133
Inventory storage (included in cost of sale) (c2)	[2]	207	313
Consulting fees (included in general and administrative) (c2)	[2]	78	95
Consulting fees (included in general and administrative) (c3)	[3]	120
Other income (c4)	[4]	(60)	(158)
Revenue Sharing Payment (included in general and administrative) (c5)	[5]	21	19
Total transactions with interested and related parties		$ 506	$ 402
[1] The Company's chief executive officer monthly salary is NIS 80 thousand (approximately $21 thousand) plus VAT. [2] On October 26, 2022, the Company and Pure Capital entered into a consulting agreement (the “Pure Capital Consulting Agreement”) pursuant to which Pure Capital will provide consultancy services to the Company for a monthly fee of NIS 57.75 thousand (approximately $16 thousand). Pursuant to the Pure Capital Consulting Agreement, Pure Capital is also entitled during the term of the Pure Capital Consulting Agreement to the following payments: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding, and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the board of directors based on the Pure Capital Consulting Agreement. In March 2023, the Company paid Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration for the investments in Fort and SciSparc. Additionally, on October 26, 2022, the Company and Pure NJ Logistics LLC, a company wholly-owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in New Jersey. On February 5, 2024, the Company paid Pure Capital $100 thousand pursuant to the terms of Pure Capital Consulting Agreement in connection with the Company’s initial public offering. On September, 4, 2024, the Company and Pure Capital signed an amendment to the Pure Capital Consulting Agreement. According to the amendment Pure Capital will be entitled to a special bonus upon the consummation of an offering of securities of the Company, including proceeds received from exercise of warrants issued, according to the below distribution, which is based on gross proceeds: (i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company. [3] On April 30, 2024, the Company entered into a consulting agreement (the “Xylo Consulting Agreement”) with Xylo Technologies Ltd. (formerly Medigus Ltd) (“Xylo”), pursuant to which Xylo will provide consultancy services to the Company for a monthly fee of $20 thousand. The Xylo Consulting Agreement is for a period of thirty-six (36) months beginning January 2024 and may be terminated for cause with thirty (30) days advance notice. The consultancy services fees paid according to the Xylo Consulting Agreement are included in other expenses. [4] On March 22, 2023, the Company entered into a consulting agreement with SciSparc (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. In November 2023 the monthly fee was reduced to $10 thousand. The consultancy services fees paid pursuant to the SciSparc Consulting Agreement are included in other income in the condensed consolidated statements of operations. [5] In April 2024, the Company paid $12 thousand to Xylo and $9 thousand to Pure Capital in connection to Revenue Sharing Payment. The outstanding payable to Xylo and Pure Capital as of June 30, 2024, is $12 thousand and $9 thousand, respectively.

v3.24.3

Related Parties — Transactions and Balances (Details) - Schedule of Balances with Interested and Related Parties - Related Party [Member] - USD ($) $ in Thousands		Jun. 30, 2024	Dec. 31, 2023
ASSETS:
Related parties		$ 53
LIABILITIES:
Liabilities		142	289
Related Party [Member]
ASSETS:
Related parties	[1]	53
LIABILITIES:
Liabilities	[2]	31	66
Chief Executive Officer Salary [Member]
LIABILITIES:
Included in other account payable	[3]	19	18
Revenue Sharing Payment [Member]
LIABILITIES:
Included in other account payable	[4]	21	21
Liability to SciSparc [Member]
LIABILITIES:
Included in other account payable	[5]		98
Liability to Xylo [Member]
LIABILITIES:
Included in other account payable	[6]	20
Liability to Supplier [Member]
LIABILITIES:
Included in trade payable	[7]	33	69
Liability to Consultant [Member]
LIABILITIES:
Included in other account payable	[7]	$ 18	$ 17
[1] On March 22, 2023, the Company entered into a consulting agreement with SciSparc (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. In November 2023 the monthly fee was reduced to $10 thousand. The consultancy services fees paid pursuant to the SciSparc Consulting Agreement are included in other income in the condensed consolidated statements of operations. [2] During the six months ended June 30, 2024 the Company paid to Xylo $25 thousand in connection with the outstanding payable amount related to Xylo employee services provided to the Company. [3] The Company's chief executive officer monthly salary is NIS 80 thousand (approximately $21 thousand) plus VAT. [4] In April 2024, the Company paid $12 thousand to Xylo and $9 thousand to Pure Capital in connection to Revenue Sharing Payment. The outstanding payable to Xylo and Pure Capital as of June 30, 2024, is $12 thousand and $9 thousand, respectively. [5] The outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand. This amount was paid on January 31, 2024. [6] On April 30, 2024, the Company entered into a consulting agreement (the “Xylo Consulting Agreement”) with Xylo Technologies Ltd. (formerly Medigus Ltd) (“Xylo”), pursuant to which Xylo will provide consultancy services to the Company for a monthly fee of $20 thousand. The Xylo Consulting Agreement is for a period of thirty-six (36) months beginning January 2024 and may be terminated for cause with thirty (30) days advance notice. The consultancy services fees paid according to the Xylo Consulting Agreement are included in other expenses. [7] On October 26, 2022, the Company and Pure Capital entered into a consulting agreement (the “Pure Capital Consulting Agreement”) pursuant to which Pure Capital will provide consultancy services to the Company for a monthly fee of NIS 57.75 thousand (approximately $16 thousand). Pursuant to the Pure Capital Consulting Agreement, Pure Capital is also entitled during the term of the Pure Capital Consulting Agreement to the following payments: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding, and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the board of directors based on the Pure Capital Consulting Agreement. In March 2023, the Company paid Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration for the investments in Fort and SciSparc. Additionally, on October 26, 2022, the Company and Pure NJ Logistics LLC, a company wholly-owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in New Jersey. On February 5, 2024, the Company paid Pure Capital $100 thousand pursuant to the terms of Pure Capital Consulting Agreement in connection with the Company’s initial public offering. On September, 4, 2024, the Company and Pure Capital signed an amendment to the Pure Capital Consulting Agreement. According to the amendment Pure Capital will be entitled to a special bonus upon the consummation of an offering of securities of the Company, including proceeds received from exercise of warrants issued, according to the below distribution, which is based on gross proceeds: (i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company.

v3.24.3

Subsequent Events (Details) - Subsequent Event [Member]		1 Months Ended
	Jul. 01, 2024 GBP (£)	Jul. 17, 2024
Subsequent Events [Line Items]
Annual rent fees (in Pounds)	£ 52,000
Board of Directors Chairman [Member] | Minimum [Member]
Subsequent Events [Line Items]
Reverse split		1
Board of Directors Chairman [Member] | Maximum [Member]
Subsequent Events [Line Items]
Reverse split		2
Chief Executive Officer [Member] | Minimum [Member]
Subsequent Events [Line Items]
Reverse split		1
Chief Executive Officer [Member] | Maximum [Member]
Subsequent Events [Line Items]
Reverse split		22

---